WaferGen Bio Financial Indicators Patterns

WGBS -- USA Stock  

USD 6.90  0.00  0.00%

Please harness WaferGen Bio systems fundamental data analysis to find out if markets are presently mispricing the firm. We found thirty-one available indicators for WaferGen Bio systems which can be compared to its rivals. To make sure the equity is not overpriced, please check out all WaferGen Bio systems fundamentals including its Price to Book, Cash Flow from Operations, Z Score, as well as the relationship between Cash and Equivalents and Total Asset . Given that WaferGen Bio systems has Number of Shares Shorted of 240.41 K, we strongly advise you confirm WaferGen Bio systems prevalent market performance to make sure the company can sustain itself down the road.Use WaferGen Bio to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment . Check odds of WaferGen Bio to be traded at $6.83 in 30 days

WaferGen Bio Company Summary

WaferGen Bio competes with Fortive, Cognex, Teradyne, Integra LifeSciences, and MKS INSTRUMENTS. WaferGen Biosystems, Inc. develops, manufactures, and sells systems for singlecell analysis and clinical research in the United States, Canada, Europe, and the Asia Pacific.

WaferGen Bio Price to Earning vs Net Income

WaferGen Bio systems is rated below average in price to earning category among related companies. It is rated below average in net income category among related companies .

WaferGen Bio systems Systematic Risk

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was six with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on WaferGen Bio systems correlated with the market. If Beta is less than 0 WaferGen Bio generally moves in the opposite direction as compared to the market. If WaferGen Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one WaferGen Bio systems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of WaferGen Bio is generally in the same direction as the market. If Beta > 1 WaferGen Bio moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

Distress Rating

WaferGen Bio Financial Distress Probability
95% 
Chance of Financial Distress
WaferGen Bio systems has more than 95 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
See also Your Current Watchlist. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.